Diabetes and obesity are significant health challenges in the U.S. and worldwide. City of Hope strives to make a difference for our patients through high-quality treatment and innovative science. Over half a century, we have built a reputation as one of the leading centers for diabetes research. Our medical team offers leading-edge diabetes care driven by City of Hope’s trademark commitment to compassion.
Diabetes is a disease in which the body does not produce or properly use insulin, a hormone needed to turn the sugar and starches people eat into energy. Nearly 40 million Americans — about 11% of the population — have diabetes, and many more are at risk for developing the disease. Source: Centers for Disease Control and Prevention.
Every patient is different, with different needs. So City of Hope treats you as a valued individual. We view diabetes care as a collaboration with patients and their caregivers. Our entire team works together to bring you precise, state-of-the-art therapy options that will deliver the best outcome for you. We support you every step of the way, helping you and your loved ones manage your condition.
Sasan Fazeli, M.D., is an endocrinologist in the Department of Diabetes, Endocrinology & Metabolism. Dr. Fazeli specializes in endocrinology with a special interest in the genetic profile of thyroid cancers, the latest adrenal and neuroendocrine tumor treatments, and advancements in the field of
Behrouz Salehian-Dardashti, M.D. is an endocrinologist specializing in treating thyroid disorders, pituitary disorders and neuroendocrine tumors. He is also director of the diabetes cardiovascular risk reduction program at City of Hope.